The Use of Zoledronic Acid to Complex Regional Pain Syndrome
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and the safety of using a single, intravenous 5mg dose of zoledronic
acid in managing pain in Complex Regional Pain Syndrome patients.